Insulin-like growth factors and their binding proteins: Biological actions

Endocrine Reviews

Volumn 16, Issue 1, 1995, Pages 3-34

  Jones, John I ^a   Clemmons, David R ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MANNOSE 6 PHOSPHATE; SOMATOMEDIN B; SOMATOMEDIN B RECEPTOR; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

CELL DIFFERENTIATION; CELL GROWTH; DRUG RECEPTOR BINDING; DWARFISM; HORMONE ACTION; HORMONE RECEPTOR INTERACTION; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

ANIMAL; HUMAN; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; RECEPTOR, IGF TYPE 1; RECEPTOR, IGF TYPE 2; SIGNAL TRANSDUCTION; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0028958031     PISSN: 0163769X     EISSN: 0163769X     Source Type: Journal    
DOI: 10.1210/edrv-16-1-3     Document Type: Article

References (345)

1. Salmon Jr WD, Daughaday WH 1957 A hormonally controlled serum factor which stimulates sulfate incorporation by cartilage in vitro. J Lab Clin Med 49:825-836
2. Daughaday WH, Reeder C 1966 Synchronous activation of DNA synthesis in hypophysectomized rat cartilage by growth hormone. J Lab Clin Med 68:357-368
3. Hall K, Uthne K 1971 Some biological properties of purified sulfation factor (SF) from human plasma. Acta Med Scand 190:137-143
4. Daughaday WH, Phillips LS, Herington AC 1975 Measurement of somatomedin by cartilage in vitro. Methods Enzymol 37B:93-109
5. Salmon Jr WD, Duvall MR 1970 In vitro stimulation of leucine incorporation into muscle and cartilage protein by a serum fraction with sulfation factor activity: differentiation of effects from those of growth hormone and insulin. Endocrinology 87:1168-1180
6. Daughaday WH, Hall K, Raben MS, Salmon WD, van den Brande JL, VanWyk JJ 1972 Somatomedin: proposed designation for sulfation factor. Nature 235:107-108
7. Froesch ER, Muller WA, Burgi H 1966 Nonsuppressible insulinlike activity of human serum. II. Biological properties of plasma extracts with nonsuppressible insulin-like activity. Biochim Biophys Acta 121:360-374
8. Solomon SS, Paffenbarger PL, Hepp DK, Feinstein LF, Ensinck JW, Williams RH1967 Quantitation and partial characterization of nonsuppressible insulin like activity in serum and tissue extracts in the rat. Endocrinology 81:213-224
9. Froesch ER, Zapf J, Audhya TK, Benporath E, Segen BJ, Gibson KD 1976 Nonsuppressible insulin like activity and thyroid hormones: major pituitary-dependent sulfation factors for cartilage. Proc Natl Acad Sci USA 73:2904-2908
10. Rinderknecht E, Humbel RE 1978 The amino acid sequence of human insulin-like growth factor I and its structural homology with proinsulin. J Biol Chem 253:2769-2776
11. Rinderknecht E, Humbel RE 1978 Primary structure of human insulin-like growth factor II. FEBS Lett 89:283-286
12. Svoboda ME, Van Wyk JJ, Klapper DG, Fellows RE, Grissom FE, Schlueter RJ 1980 Purification of somatomedin-C from human plasma: chemical and biological properties, partial sequence anal-ysis and relationship to other somatomedins. Biochemistry 19:790-797
13. Hintz RL, Clemmons DR, Underwood LE, Van Wyk JJ 1972 Competitive binding of somatomedin to the insulin receptors of adipocytes, chondrocytes, and liver membranes. Proc Natl Acad Sci USA 69:2351-2353
14. Marshall RN, Underwood LE, Voina SJ 1974 Characterization of insulin and somatomedin-C receptors in human placental cell membranes. J Clin Endocrinol Metab 39:283-292
15. Megyesi K, Kahn CR, Roth J, Neville DM, Nissler SP, Humbel RE, Froesch ER 1975 The NSILA-s receptor in liver membranes. Characterization and comparison with the insulin receptor. J Biol Chem 250:8990-8997
16. Rechler MM, Zapf J, Nissley SP 1980 Interactions of insulin-like growth factors I and II and multiplication stimulating activity with receptors and serum carrier proteins. Endocrinology 107:1451-1459
17. Massague J, Czech MP 1982 The subunit structures of two distinct receptors for insulin-like growth factor I and II and their relationship to the insulin receptor. J Biol Chem 257:5038-5045
18. Laron Z, Anin S, Klipper Aurbach Y, Klinger B 1992 Effects of insulin-like growth factor on linear growth, head circumference, and body fat in patients with Laron-type dwarfism. Lancet 339: 1258-1261
19. Behringer RR, Lewin TM, Quaife CJ, Palmiter RD, Brinster RL, D’Ercole AJ 1990 Expression of insulin-like growth factor I stimulates normal somatic growth in growth hormone-deficient transgenic mice. Endocrinology 127:1033-1040
20. Werner H, Woloschak M, Stannard B, Shen-Orr Z, Roberts Jr CT, LeRoith D1991 The insulin-like growth factor I receptor: molecular biology, heterogeneity, and regulation. In: LeRoith D (eds) InsulinLike Growth Factors: Molecular and Cellular Aspects. CRC Press, Boca Raton, pp 17-47
21. Lowe WL 1991 Biologic actions of the insulin-like growth factors. In: LeRoith D (eds) Insulin-like Growth Factors: Molecular and Cellular Aspects. CRC Press, Boca Raton, pp 49-85
22. Rechler MM 1993 Insulin-like growth factor binding proteins. Vitam Horm 47:1-114
23. Sara VR, Hall K1990 Insulin-like growth factors and their binding proteins. Physiol Rev 70:591-614
24. Czech MP 1989 Signal transmission by the insulin-like growth factors. Cell 59:235-238
25. Steele Perkins G, Turner J, Edman JC, Hari J, Pierce SB, Stover C, Rutter WJ, Roth RA 1988 Expression and characterization of a functional human insulin-like growth factor I receptor. J Biol Chem 263:11486-11492
26. Frattali AL, Pessin JE 1993 Relationship between alpha subunit ligand occupancy and beta subunit autophosphorylation in insulin/insulin-like growth factor-1 hybrid receptors. J Biol Chem 268: 7393-7400
27. Germain Lee EL, Janicot M, Lammers R, Ullrich A, Casella SJ 1992 Expression of a type I insulin-like growth factor receptor with low affinity for insulin-like growth factor II. Biochem J 281:413-417
28. Soos MA, Field CE, Lammers R, Ullrich A, Zhang B, Roth RA, Andersen AS, Kjeldsen T, Siddle K 1992 A panel of monoclonal antibodies for the type I insulin-like growth factor receptor. Epitope mapping, effects on ligand binding, and biological activity. J Biol Chem 267:12955-12963
29. Xiong L, Kasuya J, Li SL, Kato J, Fujita Yamaguchi Y 1992 Growth-stimulatory monoclonal antibodies against human insulin-like growth factor I receptor. Proc Natl Acad Sci USA 89:5356-5360
30. Flier JS, Usher P, Moses AC 1986 Monoclonal antibody to the type I insulin-like growth factor (IGF-I) receptor blocks IGF-I receptor-mediated DNA synthesis: clarification of the mitogenic mechanisms of IGF-I and insulin in human skin fibroblasts. Proc Natl Acad Sci USA 83:664-668
31. Steele Perkins G, Roth RA 1990 Monoclonal antibody alpha IR-3 inhibits the ability of insulin-like growth factor II to stimulate a signal from the type I receptor without inhibiting its binding. Biochem Biophys Res Commun 171:1244-1251
32. Kato H, Faria TN, Stannard B, Roberts CTJ, LeRoith D 1993 Role of tyrosine kinase activity in signal transduction by the insulin-like growth factor-I (IGF-I) receptor. Characterization of kinase-deficient IGF-I receptors and the action of an IGF-I-mimetic antibody (alpha IR-3). J Biol Chem 268:2655-2661
33. Schumacher R, Mosthaf L, Schlessinger J, Brandenburg D, Ullrich A 1991 Insulin and insulin-like growth factor-1 binding specificity is determined by distinct regions of their cognate receptors. J Biol Chem 266:19288-19295
34. Schumacher R, Soos MA, Schlessinger J, Brandenburg D, Siddle K, Ullrich A 1993 Signaling-competent receptor chimeras allow mapping of major insulin receptor binding domain determinants. J Biol Chem 268:1087-1094
35. Andersen AS, Kjeldsen T, Wiberg FC, Christensen PM, Rasmussen JS, Norris K, Moller KB, Moller NP1990 Changing the insulin receptor to possess insulin-like growth factor I ligand specificity. Biochemistry 29:7363-7366.
36. Andersen AS, Kjeldsen T, Wiberg FC, Vissing H, Schaffer L, Rasmussen JS, De Meyts P, Moller NP 1992 Identification of determinants that confer ligand specificity on the insulin receptor. J Biol Chem 267:13681-13686
37. Gustafson TA, Rutter WJ 1990 The cysteine-rich domains of the insulin and insulin-like growth factor I receptors are primary determinants of hormone binding specificity. Evidence from receptor chimeras. J Biol Chem 265:18663-18667
38. Frattali AL, Treadway JL, Pessin JE 1992 Transmembrane signaling by the human insulin receptor kinase. J Biol Chem 267:19521-19528
39. Treadway JL, Morrison BD, Soos MA, Siddle K, Olefsky J, Ullrich A, McClain DA, Pessin JE 1991 Transdominant inhibition of tyrosine kinase activity in mutant insulin/insulin-like growth factor I hybrid receptors. Proc Natl Acad Sci USA 88:214-218
40. Taylor SI, Cama A, Accili D, Barbetti F, Quon MJ, de la Luz-Sierra M, Suzuki Y, Koller E, Levy-Toledano R, Wertheimer E 1992 Mutations in the insulin receptor gene. Endocr Rev 13:566-595
41. Yamasaki H, Prager D, Gebremedhin S, Melmed S 1992 Human insulin-like growth factor I receptor 950tyrosine is required for somatotroph growth factor signal transduction. J Biol Chem 267: 20953-20958
42. Yamasaki H, Prager D, Melmed S 1993 Structure-function of the human insulin-like growth factor-I receptor: a discordance of somatotroph internalization and signaling. Mol Endocrinol 7:681-685
43. Izumi T, White MF, Takashi K, Takaku F, Akanuma Y, Kusuga M 1987 Insulin like growth factor I rapidly stimulates tyrosine phosphorylation of a Mr 185000 protein in intact cells. J Biol Chem 262:1282-1287
44. Sun XJ, Rothenberg P, Kahn CR, Backer JM, Araki E, Wilden PA, Cahill DA, Goldstein BJ, White MF 1991 The structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein. Nature 352:73-77
45. Myers Jr MG, White MF 1993 The new elements of insulin signaling: insulin receptor substrate-1 and proteins with SH2 domains. Diabetes 42:643-650
46. White MF, Kahn CR 1994 The insulin signaling system. J Biol Chem 269:1-4
47. Myers Jr MG, Backer JM, Sun XJ, Shoelson S, Hu P, Schlessinger J, Yoakim M, Schaffhausen B, White MF 1992 IRS-1 activates phosphatidylinositol 3’-kinase by associating with src homology 2 domains of p85. Proc Natl Acad Sci USA 89:10350-10354
48. Myers MGJ, Sun XJ, Cheatham B, Jachna BR, Glasheen EM, Backer JM, White MF 1993 IRS-1 is a common element in insulin and insulin-like growth factor-I signaling to the phosphatidylinositol 3’-kinase. Endocrinology 132:1421-1430
49. Yamamoto K, Lapetina EG, Moxham CP 1992 Insulin like growth factor-I induces limited association of phosphatidylinositol 3-kinase to its receptor. Endocrinology 130:1490-1498
50. Giorgetti S, Ballotti R, Kowalski Chauvel A, Tartare S, Van Ob-berghen E 1993 The insulin and insulin-like growth factor-I receptor substrate IRS-1 associates with and activates phosphatidylinositol 3-kinase in vitro. J Biol Chem 268:7358-7364
51. Baltensperger K, Kozma LM, Cherniak AD, Klarlund JK, Chawla A, Banerjee U, Czech MP 1993 Binding of the ras activator son of sevenless to insulin receptor substrate-1 signaling complexes. Science 260:1950-1952
52. Skolnik EY, Batzer A, Li N, Lee C-H, Lowenstein E, Mohammadi M, Schlessinger J 1993 The function of GRB2 in linking the insulin receptor to ras signaling pathways. Science 260:1953-1955
53. Chuang L-M, Myers Jr MG, Seidner GA, Bimbaum MJ, White MF, Kahn CR 1993 Insulin receptor substrate 1 mediates insulin and insulin-like growth factor I-stimulated maturation of Xenopus oocytes. Proc Natl Acad Sci USA 90:5172-5175
54. Blenis J 1993 Signal transduction via the MAP kinases: proceed at your own RSK. Proc Natl Acad Sci USA 90:5889-5892
55. Yamamoto K, Altschuler D, Wood E, Horlick K, Jacobs S, Lapetina EG 1992 Association of phosphorylated insulin-like growth factor-I receptor with the SH2 domains of phosphatidyl-inositol 3-kinase p85. J Biol Chem 267:11337-11343
56. Kuhne MR, Pawson T, Lienhard GE, Feng G-S 1993 The insulin receptor substrate-1 associates with the SH2-containing phospho-tyrosine phosphatase Syp. J Biol Chem 268:11479-11481
57. Lee C-H, Li W, Nishimura R, Zhou M, Batzer AG, Myers Jr MG, White MF, Schlessinger J, Skolnik EY1993 Nek associates with the SH2 domain-docking protein IRS-1 in insulin-stimulated cells. Proc Natl Acad Sci USA 90:11713-11717
58. Sun XJ, Crimmins DL, Myers Jr MG, Miralpeix M, White MF 1993 Pleiotropic insulin signals are engaged by multisite phosphorylation of IRS-1. Mol Cell Biol 13:7418-7428
59. Chao MV 1992 Growth factor signaling: where is the specificity? Cell 68:995-997
60. Pelicci G, Lanfrancone L, Grignani F, McGlade J, Cavallo F, Fomi G, Nicoletti I, Pawson T, Pellici PG 1992 A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction. Cell 70:93-104
61. Skolnik EY, Lee C-H, Batzer A, Vicentini LM, Zhou M, Daly R, Myers Jr MG, Backer JM, Ullrich A, White MF, Schlessinger J 1993 The SH2/SH3 domain-containing protein GRB2 interacts with tyrosine-phosphorylated IRS-1 and She: implications for insulin control of ras signaling. EMBO J 12:1929-1936
62. Wang LM, Keegan AD, Li W, Lienhard GE, Pacini S, Gutkind JS, Myers MGJ, Sun XJ, White MF, Aaronson SA, Paul WE, Pierce JH 1993 Common elements in interleukin 4 and insulin signaling pathways in factor-dependent hematopoietic cells. Proc Natl Acad Sci USA 90:4032-4036
63. Condorelli G, Formisano P, Villone G, Smith RJ, Beguinot F1989 Insulin and insulin-like growth factor I (IGF I) stimulate phosphorylation of a Mr 175, 000 cytoskeleton-associated protein in intact FRTL5 cells. J Biol Chem 264:12633-12638
64. McClain DA, Maegawa H, Thies RS, Olefsky JM 1990 Dissection of the growth vs. metabolic effects of insulin and insulin-like growth factor-I in transfected cells expressing kinase-defective human insulin receptors. J Biol Chem 265:1678-1682
65. Kato H, Faria TN, Stannard B, Roberts Jr CT, LeRoith D 1994 Essential role of tyrosine residues 1131, 1135, and 1136 of the insulin-like growth factor-I (IGF-I) receptor in IGF-I action. Mol Endocrinol 8:40-50
66. Treadway JL, Frattali AL, Pessin JE 1992 Intramolecular subunit interactions between insulin and insulin-like growth factor 1 alpha beta halfreceptors induced by ligand and Mn/MgATP binding. Biochemistry 31:11801-11805
67. Treadway JL, Morrison BD, Frattali AL, Pessin JE 1991 Transmembrane signaling of insulin/IGF-1 hybrid receptors. In: Spencer EM (eds) Modem Concepts of Insulin-like Growth Factors. Elsevier, New York, pp 449-459
68. Soos MA, Siddle K 1989 Immunological relationships between receptors for insulin and insulin-like growth factor I. Evidence for structural heterogeneity of insulin-like growth factor I receptors involving hybrids with insulin receptors. Biochem J 263:553-563
69. Soos MA, Field CE, Siddle K1993 Purified hybrid insulin/insulinlike growth factor-I receptors bind insulin-like growth factor-I, but not insulin, with high affinity. Biochem J 290:419-426
70. Moxham CP, Duronio V, Jacobs S 1989 Insulin-like growth factor I receptor beta-subunit heterogeneity. Evidence for hybrid tetram-ers composed of insulin-like growth factor I and insulin receptor heterodimers. J Biol Chem 264:13238-13244
71. Alexandrides TK, Smith RJ 1989 A novel fetal insulin-like growth factor (IGF) I receptor. Mechanism for increased IGF I-and insulin-stimulated tyrosine kinase activity in fetal muscle. J Biol Chem 264:12922-12930
72. Prager D, Yamasaki H, Weber MM, Gebremedhin S, Melmed S 1992 Human insulin-like growth factor I receptor function in pituitary cells is suppressed by a dominant negative mutant. J Clin Invest 90:2117-2122
73. Nissley SP, Kiess W, Sklar MM 1991 The insulin-like growth factor-II/mannose-6-phosphate receptor. In: LeRoith D (eds) Insulin-like Growth Factors: Cellular and Molecular Aspects. CRC Press, Boca Raton, pp 111-150
74. Nielsen FC 1992 The molecular and cellular biology of insulin-like growth factor II. Prog Growth Factor Res 4:257-290
75. Faust PL, Chirgwin JA, Komfeld S 1987 Renin, a secretory glycoprotein, acquires phosphomannosyl residues. J Cell Biol 105: 1947-1955
76. Lee SJ, Nathans D 1988 Proliferin secreted by cultured cells binds to mannose 6-phosphate receptors. J Biol Chem 263:3521-3527
77. Herzog V, Neumuller W, Holzmann B 1987 Thyroglobulin, the major and obligatory exportable protein of thyroid follicular cells, carries the lysosomal recognition marker mannose 6-phosphate. EMBO J 6:555-560
78. Purchio AF, Cooper JA, Brunner AM, Lioubin MN, Gentry LE, Kovacina KS, Roth FLA, Marquardt H 1988 Identification of mannose 6-phosphate in two asparagine-linked sugar chains of recombinant transforming growth factor-β1 precursor. J Biol Chem 263: 14211-14215
79. Dennis PA, Rifkin DB 1991 Cellular activation of latent transforming growth factor beta requires binding to the cation-independent mannose 6-phosphate/insulin-like growth factor type II receptor. Proc Natl Acad Sci USA 88:580-584
80. Lonnroth P, Assmundsson K, Eden S, Enberg G, Gause I, Hall K, Smith U 1987 Regulation of insulin-like growth factor II receptors by growth hormone and insulin in rat adipocytes. Proc Natl Acad Sci USA 84:3619-3622
81. Braulke T, Tippmer S, Neher E, von Figura K 1989 Regulation of the mannose 6-phosphate/IGF II receptor expression at the cell surface by mannose 6-phosphate, insulin like growth factors and epidermal growth factor. EMBO J 8:681-686
82. Corvera S, Czech MP 1985 Mechanism of insulin action on membrane protein recycling: a selective decrease in the phosphorylation state of insulin-like growth factor II receptors in the cell surface membrane. Proc Natl Acad Sci USA 82:7314-7318
83. Corvera S, Folander K, Clairmont KB, Czech MP 1988 A highly phosphorylated subpopulation of insulin-like growth factor II/mannose 6-phosphate receptors is concentrated in a clathrin-en-riched plasma membrane fraction. Proc Natl Acad Sci USA 85: 7567-7571
84. Braulke T, Causin C, Waheed A, Junghans U, Hasilik A, Maly P, Humbel RE, von Figura K1988 Mannose 6-phosphate/insulin-like growth factor II receptor: distinct binding sites for mannose 6-phosphate and insulin-like growth factor II. Biochem Biophys Res Commun 150:1287-1293
85. Kiess W, Blickenstaff GD, Sklar MM, Thomas CL, Nissley SP, Sahagian GG 1988 Biochemical evidence that the type II insulinlike growth factor receptor is identical to the cation-independent mannose 6-phosphate receptor. J Biol Chem 263:9339-9344
86. Kiess W, Thomas CL, Sklar MM, Nissley SP 1990 Beta-galacto-sidase decreases the binding affinity of the insulin-like-growth-factor-II/mannose-6-phosphate receptor for insulin-like-growth-factor II. Eur J Biochem 190:71-77
87. Oka Y, Rozek LM, Czech MP 1985 Direct demonstration of rapid insulin-like growth factor II receptor internalization and recycling in rat adipocytes. Insulin stimulates 1251-insulin-like growth factor II degradation by modulating the IGF-II receptor recycling process. J Biol Chem 260:9435-9442
88. Clairmont KB, Czech MP 1991 Extracellular release as the major degradative pathway of the insulin-like growth factor II/mannose 6-phosphate receptor. J Biol Chem 266:12131-12134
89. Bobek G, Scott CD, Baxter RC1992 Radioimmunoassay of soluble insulin-like growth factor-II/mannose 6-phosphate receptor: developmental regulation of receptor release by rat tissues in culture. J Clin Endocrinol Metab 130:3387-3394
90. Clairmont KB, Czech MP 1989 Chicken and Xenopus mannose 6-phosphate receptors fail to bind insulin-like growth factor II. J Biol Chem 264:16390-16392
91. Filson AJ, Louvi A, Efstratiadis A, Robertson EJ1993 Rescue of the T-associated maternal effect in mice carrying null mutations in Igf-2 and Igf2r, two reciprocally imprinted genes. Development 118: 731-736
92. Barlow DP, Stoger R, Herrmann BG, Saito K, Schweifer N 1991 The mouse insulin-like growth factor type-2 receptor is imprinted and closely linked to the Tme locus. Nature 349:84-87
93. DeChiara TM, Efstratiadis A, Robertson EJ 1990 A growth-defi-ciency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting. Nature 345:78-80
94. DeChiara TM, Robertson EJ, Efstratiadis A 1991 Parental imprinting of the mouse insulin-like growth factor II gene. Cell 64:849-859
95. Haig D, Graham C 1991 Genomic imprinting and the strange case of the insulin-like growth factor II receptor. Cell 64:1045-1046
96. Kalscheuer VM, Mariman EC, Schepens MT, Rehder H, Ropers H-H 1993 The insulin-like growth factor type-2 receptor gene is imprinted in the mouse but not in humans. Nature Genet 5:74-77
97. Giannoukakis N, Deal C, Paquette J, Goodyer CG, Polychrona-kos C 1993 Parental genomic imprinting of the human IGF2 gene. Nature Genet 4:98-100
98. Ohlsson R, Nystrom A, Pfeifer-Ohlsson S, Tohonen V, Hedborg F, Schofield P, Flam F, Ekstrom TJ 1993 IGF2 is parentally imprinted during human embryogenesis and in the Beckwith-Wiede-mann syndrome. Nature Genet 4:94-97
99. Mottola C, Czech MP 1984 The type II insulin-like growth factor receptor does not mediate increased DNA synthesis in H-35 hepatoma cells. J Biol Chem 259:12705-12713
100. Hartmann H, Meyer Alber A, Braulke T 1992 Metabolic actions of insulin-like growth factor II in cultured adult rat hepatocytes are not mediated through the insulin-like growth factor II receptor. Diabetologia 35:216-223
101. Kiess W, Haskell JF, Lee L 1987 An antibody that blocks insulin like growth factor (IGF) binding to the type II IGF receptor is neither against nor an inhibitor of IGF stimulated biologic responses in L-6 myoblasts. J Biol Chem 262:12745-12751
102. Adashi EY, Resnick CE, Rosenfeld RG 1990 Insulin-like growth factor-I (IGF-I) and IGF-II hormonal action in cultured rat granulosa cells: mediation via type I but not type II IGF receptors. Endocrinology 126:216-222
103. Stracke ML, Engel JD, Wilson LW, Rechler MM, Liotta LA, Schiffmann E 1989 The type I insulin-like growth factor receptor is a motility receptor in human melanoma cells. J Biol Chem 264: 21544-21549
104. Hirai K, Miyamasu M, Yamaguchi M, Nakajima K, Ohtoshi T, Koshino T, Takaishi T, Morita Y, Ito K1993 Modulation of human basophil histamine release by insulin-like growth factors. J Immunol 150:1503-1508
105. Weber MM, Melmed S, Rosenbloom J, Yamasaki H, Prager D 1992 Rat somatotroph insulin-like growth factor-II (IGF-II) signaling: role of the IGF-I receptor. Endocrinology 131:2147-2153
106. Minniti CP, Kohn EC, Grubb JH, Sly WS, Oh Y, Muller HL, Rosenfeld RG, Helman LJ 1992 The insulin-like growth factor II (IGF-II)/mannose 6-phosphate receptor mediates IGF-II-induced motility in human rhabdomyosarcoma cells. J Biol Chem 267:9000-9004
107. Nishimoto I, Murayama Y, Katada T, Ui M, Ogata E 1989 Possible direct linkage of insulin-like growth factor-II receptor with guanine nucleotide-binding proteins. J Biol Chem 264:14029-14038
108. Murayama Y, Okamoto T, Ogata E, Asano T, Iiri T, Katada T, Ui M, Grubb JH, Sly WS, Nishimoto I 1990 Distinctive regulation of the functional linkage between the human cation-independent mannose 6-phosphate receptor and GTP-binding proteins by insulin-like growth factor II and mannose 6-phosphate. J Biol Chem 265:17456-17462
109. Nishimoto I, Hata Y, Ogata E, Kojima L 1987 Insulin-like growth factor II stimulates calcium influx in competent BALB/c 3T3 cells primed with epidermal growth factor. Characteristics of calcium influx and involvement of GTP-binding protein. J Biol Chem 262: 12120-12126
110. Kojima I, Nishimoto I, Iiri T, Ogata E, Rosenfeld R 1988 Evidence that type II insulin-like growth factor receptor is coupled to calcium gating system. Biochem Biophys Res Commun 154:9-19
111. Giudice LC 1992 Insulin-like growth factors and ovarian follicular development. Endocr Rev 13:641-669
112. McCauley VM 1992 Insulin-like growth factors and cancer. Br J Cancer 65:311-320
113. Cohick WS, Clemmons DR 1993 The insulin-like growth factors. Annu Rev Physiol 55:131-153
114. Lu K, Campisi J 1992 Ras proteins are essential and selective for the action of insulin-like growth factor 1 late in the G1 phase of the cell cycle in BALB/c murine fibroblasts. Proc Natl Acad Sci USA 89:3889-3893
115. Travali S, Reiss K, Ferber A, Petralia S, Mercer WE, Calabretta B, Baserga R 1991 Constitutively expressed c-myb abrogates the requirement for insulinlike growth factor 1 in 3T3 fibroblasts. Mol Cell Biol 11:731-736
116. Porcu P, Ferber A, Pietrzkowski Z, Roberts CT, Adamo M, LeRoith D, Baserga R 1992 The growth-stimulatory effect of simian virus 40 T antigen requires the interaction of insulin-like growth factor 1 with its receptor. Mol Cell Biol 12:5069-5077
117. Pietrzkowski Z, Sell C, Lammers R, Ullrich A, Baserga R 1992 Roles of insulinlike growth factor 1 (IGF-1) and the IGF-1 receptor in epidermal growth factor-stimulated growth of 3T3 cells. Mol Cell Biol 12:3883-3889
118. Clemmons DR, Shaw DS 1983 Variables controlling somatomedin production by cultured human fibroblasts. J Cell Physiol 115:137-143
119. Baserga R, Rubin R 1993 Cell cycle and growth control. Crit Rev Eukaryotic Gene Expression 3:47-61
120. Yoshinouchi M, Miura M, Gaozza E, Shi-Wei L, Baserga R 1993 Basic fibroblast growth factor stimulates DNA synthesis in cells overexpressing the insulin-like growth factor-I receptor. Mol Endocrinol 7:1161-1168
121. McCubrey JA, Steelman LS, Mayo MW, Algate PA, Dellow RA, Kaleko M 1991 Growth-promoting effects of insulin-like growth factor-1 (IGF-1) on hematopoietic cells: overexpression of introduced IGF-1 receptor abrogates interleukin-3 dependency of murine factor-dependent cells by a ligand-dependent mechanism. Blood 78:921-929
122. Kaleko M, Rutter WJ, Miller AD 1990 Overexpression of the human insulinlike growth factor I receptor promotes ligand-dependent neoplastic transformation. Mol Cell Biol 10:464-473
123. Bohme K, Conscience Egli M, Tschan T, Winterhalter KH, Bruckner P 1992 Induction of proliferation or hypertrophy of chondrocytes in serum-free culture: the role of insulin-like growth factor-I, insulin, or thyroxine. J Cell Biol 116:1035-1042
124. Barreca A, De Luca M, Del Monte P, Bondanza S, Damonte G, Cariola G, Di Marco E, Giordano G, Cancedda R, Minuto F 1992 In vitro paracrine regulation of human keratinocyte growth by fibroblast-derived insulin-like growth factors. J Cell Physiol 151: 262-268
125. Dai Z, Takahashi SI, Van Wyk JJ, D’Ercole AJ 1992 Creation of an autocrine model of insulin-like growth factor-I action in transfected FRTL-5 cells. Endocrinology 130:3175-3183
126. Dai Z, Stiles AD, Moats Staats B, Van Wyk JJ, D’Ercole AJ 1992 Interaction of secreted insulin-like growth factor-I (IGF-I) with cell surface receptors is the dominant mechanism of IGF-I’s autocrine actions. J Biol Chem 267:19565-19571
127. Han VK, Smith A, Myint W, Nygard K, Bradshaw S 1992 Mito-genic activity of epidermal growth factor on newborn rat astroglia: interaction with insulin-like growth factors. Endocrinology 131: 1134-1142
128. Timsit J, Savino W, Safieh B, Chanson P, Gagnerault MC, Bach JF, Dardenne M 1992 Growth hormone and insulin-like growth factor-I stimulate hormonal function and proliferation of thymic epithelial cells. J Clin Endocrinol Metab 75:183-188
129. Merchav S, Silvian Drachsler I, Tatarsky I, Lake M, Skottner A 1992 Comparative studies of the erythroid-potentiating effects of biosynthetic human insulin-like growth factors-I and-II. J Clin Endocrinol Metab 74:447-452
130. Merchav S, Graif Z, Skottner A 1993 In-vitro response of erythroid pregenitors from children with thalassaemia major to human growth hormone and insulin-like growth factor I. Clin Endocrinol (Oxf) 39:207-211
131. Kooijman R, Willems M, Rijkers GT, Brinkman A, Van Buul Offers SC, Heijnen CJ, Zegers BJ 1992 Effects of insulin-like growth factors and growth hormone on the in vitro proliferation of T lymphocytes. J Neuroimmunol 38:95-104
132. Bley MA, Simon JC, Estevez AG, de Asua LJ, Baranao JL 1992 Effect of follicle-stimulating hormone on insulin-like growth factor-I-stimulated rat granulosa cell deoxyribonucleic acid synthesis. Endocrinology 131:1223-1229
133. Soder O, Bang P, Wahab A, Parvinen M 1992 Insulin-like growth factors selectively stimulate spermatogonial, but not meiotic, deoxyribonucleic acid synthesis during rat spermatogenesis. Endocrinology 131:2344-2350
134. Williams GT, Smith CA, Spooncer E, Dexter TM, Taylor DR 1990 Haemopoietic colony stimulating factors promote cell survival by suppressing apoptosis. Nature 343:76-79
135. Muta K, Krantz SB 1993 Apoptosis of human erythroid colony forming cells is decreased by stem cell factor and insulin-like growth factor I as well as erythropoietin. J Cell Physiol 156:264-271
136. Rodriguez Tarduchy G, Collins MK, Garcia I, Lopez Rivas A 1992 Insulin-like growth factor-I inhibits apoptosis in IL-3-dependent hemopoietic cells. J Immunol 149:535-540
137. Geier A, Haimshon M, Beery R, Hemi R, Lunenfeld B 1993 Insulin-like growth factor-I inhibits cell death induced by cyclohex-imide in MCF-7 cells: a model system for analyzing control of cell death. In Vitro Cell Dev Biol 28A:725-729
138. Geier A, Hemi R, Haimson M, Beery R 1993 Epidermal growth factor and insulin-like growth factor-1 preserve cell viability in the absence of protein synthesis. In Vitro Cell Dev Biol 29A:231-234
139. Florini JR, Magri KA 1989 Effects of growth factors on myogenic differentiation. Am J Physiol 256:C701-C711
140. Florini JR, Ewton DZ 1990 Highly specific inhibition of IGF-I-stimulated differentiation by an antisense oligodeoxyribonucle-otide to myogenin mRNA. No effects on other actions of IGF-I. J Biol Chem 265:13435-13437
141. Florini JR, Ewton DZ, Roof SL 1991 Insulin-like growth factor-I stimulates terminal myogenic differentiation by induction of myogenin gene expression. Mol Endocrinol 5:718-724
142. Florini JR, Magri KA, Ewton DZ, James PL, Grindstaff K, Rotwein PS 1991 “Spontaneous” differentiation of skeletal myoblasts is dependent upon autocrine secretion of insulin-like growth factor-II. J Biol Chem 266:15917-15923
143. Florini JR, Ewton DZ, Falen SL, Van Wyk JJ 1986 Biphasic concentration dependency of stimulation of myoblast differentiation by somatomedins. Am J Physiol 250:C771-C778
144. Quinn LS, Ehsan M, Steinmetz B, Kaleko M 1993 Ligand-dependent inhibition of myoblast differentiation by overexpression of the type-I insulin-like growth factor receptor. J Cell Physiol 156:453461
145. Mochizuki H, Hakeda Y, Wakatsuki N, Usui N, Akashi S, Sato T, Tanaka K, Kumegawa M 1992 Insulin-like growth factor-I supports formation and activation of osteoclasts. Endocrinology 131: 1075-1080
146. Geduspan JS, Solursh M 1993 Effects of the mesonephros and insulin-like growth factor I on chondrogenesis of limb explants. Dev Biol 156:500-508
147. Pahlman S, Meyerson G, Lindgren E, Schalling M, Johansson I 1991 Insulin-like growth factor I shifts from promoting cell division to potentiating maturation during neuronal differentiation. Proc Natl Acad Sci USA 88:9994-9998
148. Penhoat A, Naville D, Jaillard C, Chatelain PG, Saez JM 1989 Hormonal regulation of insulin-like growth factor I secretion by bovine adrenal cells. J Biol Chem 264:6858-6862
149. Penhoat A, Jaillard C, Saez JM 1989 Synergistic effects of corticotropin and insulin-like growth factor I on corticotropin receptors and corticotropin responsiveness in cultured bovine adrenocortical cells. Biochem Biophys Res Commun 165:355-359
150. Yamasaki H, Prager D, Gebremedhin S, Moise L, Melmed S 1991 Binding and action of insulin-like growth factor I in pituitary tumor cells. Endocrinology 128:857-862
151. Yamasaki H, Prager D, Gebremedhin S, Melmed S 1991 Insulinlike growth factor-I (IGF-I) attenuation of growth hormone is enhanced by overexpression of pituitary IGF-I receptors. Mol Endocrinol 5:890-896
152. Kooijman R, Willems M, De Haas CJ, Rijkers GT, Schuurmans AL, Van Buul Offers SC, Heijnen CJ, Zegers BJ 1992 Expression of type I insulin-like growth factor receptors on human peripheral blood mononuclear cells. Endocrinology 131:2244-2250
153. Castro-Alamancos MA, Torres-Aleman 11993 Long-term depression of glutamate-induced gamma-aminobutyric acid release in cerebellum by insulin-like growth factor I. Proc Natl Acad Sci USA 90:7386-7390
154. Tapson VF, Boni Schnetzler M, Pilch PF, Center DM, Berman JS 1988 Structural and functional characterization of the human T lymphocyte receptor for insulin-like growth factor I in vitro. J Clin Invest 82:950-957
155. Shoji S, Ertl RF, Linder J, Koizumi S, Duckworth WC, Rennard SI 1990 Bronchial epithelial cells respond to insulin and insulin-like growth factor-I as a chemoattractant. Am J Respir Cell Mol Biol 2:553-557
156. Grant M, Jerdan J, Merimee TJ 1987 Insulin-like growth factor-I modulates endothelial cell chemotaxis. J Clin Endocrinol Metab 65:370-371
157. Grant MB, Guay C, Marsh R 1990 Insulin-like growth factor I stimulates proliferation, migration, and plasminogen activator release by human retinal pigment epithelial cells. Curr iye Res 9:323-335
158. Ando Y, Jensen PJ 1993 Epidermal growth factor and insulin-like growth factor I enhance keratinocyte migration. J Invest Dermatol 100:633-639
159. Trojan J, Blossey BK, Johnson TR, Rudin SD, Tykocinski M, Ilan J 1992 Loss of tumorigenicity of rat glioblastoma directed by episome-based antisense cDNA transcription of insulin-like growth factor I. Proc Natl Acad Sci USA 89:4874-4878
160. Trojan J, Johnson TR, Rudin SD, Ilan J, Tykocinski ML 1993 Treatment and prevention of rat glioblastoma by immunogenic C6 cells expressing antisense insulin-like growth factor IRNA. Science 259:94-97
161. Dimitriadis G, Parry Billings M, Bevan S, Dunger D, Piva T, Krause U, Wegener G, Newsholme EA 1992 Effects of insulin-like growth factor I on the rates of glucose transport and utilization in rat skeletal muscle in vitro. Biochem J 285:269-274
162. Hill DJ, Logan A, McGarry M, de Sousa D 1992 Control of protein and matrix-molecule synthesis in isolated ovine fetal growth-plate chondrocytes by the interactions of basic fibroblast growth factor, insulin-like growth factors-I and-II, insulin and transforming growth factor-beta 1. J Endocrinol 133:363-373
163. Trippel SB, Corvol MT, Dumontier MF, Rappaport R, Hung HH, Mankin HJ 1989 Effect of somatomedin-C/insulin-like growth factor I and growth hormone on cultured growth plate and articular chondrocytes. Pediatr Res 25:76-82
164. Roberts Jr CT, Lasky SR, Lowe Jr WL, Seaman WT, LeRoith D 1987 Molecular cloning of rat insulin-like growth factor I complementary deoxyribonucleic acids: differential messenger ribonucleic acid processing and regulation by growth hormone in extrahepatic tissues. Mol Endocrinol 1:243-248
165. Hynes MA, Van Wyk JJ, Brooks PJ, D’Ercole AJ, Jansen M, Lund PK 1987 Growth hormone dependence of somatomedin-C/insulinlike growth factor-I and insulin-like growth factor-II messenger ribonucleic acids. Mol Endocrinol 1:233-242
166. Davis SR, Hodgkinson SC, Prosser CG, Gluckman PD, Buonomo FC, Collier RJ 1992 Effect of growth hormone treatment on the distribution of insulin-like growth factor-I between plasma and lymph of lactating sheep. J Endocrinol 132:339-344
167. Jennische E, Isgaard J, Isaksson OGP 1992 Local expression of insulin-like growth factors during tissue growth and regeneration. In: Schofield PN (eds) The Insulin-like Growth Factors. Structure and Biological Functions. Oxford, New York, pp 221-239
168. Chin E, Zhou J, Bondy C 1992 Anatomical relationships in the patterns of insulin-like growth factor (IGF)-I, IGF binding protein-1, and IGF-I receptor gene expression in the rat kidney. Endocrinology 130:3237-3245
169. Murphy LJ, Murphy LC, Friesen HG 1987 Estrogen induces insulin-like growth factor-I expression in the rat uterus. Mol Endocrinol 1:445-450
170. Han VKM, D’Ercole AJ, Lund PK 1987 Cellular location of somatomedin (insulin-like growth factor) messenger RNA in the human fetus. Science 236:193-197
171. Han VK, Lund PK, Lee DC, D’Ercole AJ 1988 Expression of somatomedin/insulin-like growth factor messenger ribonucleic acids in the human fetus: identification, characterization, and tissue distribution. J Clin Endocrinol Metab 66:422-429
172. Han VKM, Hill DJ 1992 The involvement of insulin-like growth factors in embryonic and fetal development. In: Schofield PN (eds) The Insulin-like Growth Factors. Structure and Biological Functions. Oxford, New York, pp 178-220
173. Daughaday WH, Rotwein P 1989 Insulin-like growth factors I and Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations. Endocr Rev 10:68-91
174. Zapf J, Hauri C, Waldvogel M, Froesch ER 1986 Acute metabolic effects and half-lives of intravenously administered insulin-like growth factors I and II in normal and hypophysectomized rats. J Clin Invest 77:1768-1775
175. Jacob R, Barrett E, Plewe G, Fagin KD, Sherwin RJ 1989 Acute effects of insulin-like growth factor-I on glucose and amino acid metabolism in the awake fasted rat. J Clin Invest 83:1717-1723
176. Rossetti L, Frontoni S, Dimarchi R, DeFronzo RA, Giaccari A 1991 Metabolic effects of IGF-I in diabetic rats. Diabetes 40:444-448
177. Tomas FM, Knowles SE, Owens PC, Chandler CS, Francis GL, Read LC, Ballard FJ 1992 Insulin-like growth factor-I (IGF-I) and especially IGF-I variants are anabolic in dexamethasone-treated rats. Biochem J 282:91-97
178. O’Sullivan U, Gluckman PD, Breier BH, Woodall S, Siddiqui RA, McCutcheon SN 1989 Insulin-like growth factor-I (IGF-I) in mice reduces weight loss during starvation. Endocrinology 125:2793-2794
179. Douglas RG, Gluckman PD, Ball K, Breier B, Shaw JH 1991 The effects of infusion of insulin-like growth factor (IGF) I, IGF-II, and insulin on glucose and protein metabolism in fasted lambs. J Clin Invest 88:614-622
180. Thissen JP, Underwood LE, Maiter DM, Maes M, Clemmons DR, Ketelslegers JM 1991 Failure of IGF-I infusion to promote growth in protein-restricted rats despite normalization of serum IGF-I concentrations. Endocrinology 128:885-890
181. Ding H, Kopple JD, Cohen A, Hirschberg R 1993 Recombinant human insulin-like growth factor-I accelerates recovery and reduces catabolism in rats with ischemic acute renal failure. J Clin Invest 91:2281-2287
182. Miller SB, Martin DR, Kissane J, Hammerman MR 1992 Insulinlike growth factor I accelerates recovery from ischemic acute tubular necrosis in the rat. Proc Natl Acad Sci USA 89:11876-11880
183. Suh DY, Hunt TK, Spencer EM 1992 Insulin-like growth factor-I reverses the impairment of wound healing induced by corticosteroids in rats. Endocrinology 131:2399-2403
184. Pell JM, Bates PC 1992 Differential actions of growth hormone and insulin-like growth factor-I on tissue protein metabolism in dwarf mice. Endocrinology 130:1942-1950
185. Guler HP, Zapf J, Scheiwiller E, Froesch ER 1988 Recombinant human insulin-like growth factor I stimulates growth and has distinct effects on organ size in hypophysectomized rats. Proc Natl Acad Sci USA 85:4889-4893
186. Schoenle E, Zapf J, Humbel RE, Froesch ER 1982 Insulin-like growth factor I stimulates growth in hypophysectomized rats. Nature 296:252-253
187. Skottner A, Clark RG, Fryklund L, Robinson IC 1989 Growth responses in a mutant dwarf rat to human growth hormone and recombinant human insulin-like growth factor I. Endocrinology 124:2519-2526
188. Hirschberg R, Kopple JD, Blantz RC, Tucker BJ 1991 Effects of recombinant human insulin-like growth factor I on glomerular dynamics in the rat. J Clin Invest 87:1200-1206
189. Hirschberg R, Kopple JD 1989 Evidence that insulin-like growth factor I increases renal plasma flow and glomerular filtration rate in fasted rats. J Clin Invest 83:326-330.
190. Olanrewaju H, Patel L, Seidel ER 1992 Trophic action of local intraileal infusion of insulin-like growth factor I: polyamine dependence. Am J Physiol 263:E282-E286
191. Clemmons DR, Thissen JP, Maes M, Ketelslegers JM, Underwood LE 1989 Insulin-like growth factor-I (IGF-I) infusion into hypophysectomized or protein-deprived rats induces specific IGF binding proteins in serum. Endocrinology 125:2967-2972
192. Zapf J, Hauri C, Waldvogel M, Futo E, Hasler H, Binz K, Guler HP, Schmid C, Froesch ER 1989 Recombinant human insulin-like growth factor I induces its own specific carrier protein in hypophysectomized and diabetic rats. Proc Natl Acad Sci USA 86:3813-3817
193. Scheiwiller E, Guler HP, Merryweather J, Scandella C, Maerki W 1986 Growth restoration of insulin-deficient diabetic rats by recombinant human insulin-like growth factor-I. Nature 323:169-171
194. Jacob RJ, Sherwin RS, Bowen L, Fryburg D, Fagin KD, Tambor-lane WV, Shulman GI 1991 Metabolic effects of IGF-I and insulin in spontaneously diabetic BB/w rats. Am J Physiol 260:E262-E268
195. Rosetti L, Frontoni S, Dimarchi R, DeFronzo RA, Giaccari A1991 Metabolic effects of IGF-I in diabetic rats. Diabetes 40:444-448
196. Binz K, Joller P, Froesch P, Binz H, Zapf J, Froesch ER 1990 Repopulation of the atrophied thymus in diabetic rats by instriinlike growth factor I. Proc Natl Acad Sci USA 87:3690-3694
197. Sinha MK, Buchanan C, Leggett N, Martin L, Khazanie PG, Dimarchi R, Pories WJ, Caro JF 1989 Mechanism of IGF-I-stimulated glucose transport in human adipocytes. Demonstration of specific IGF-I receptors not involved in stimulation of glucose transport. Diabetes 38:1217-1225
198. D’Ercole AJ 1993 Expression of insulin-like growth factor-I in transgenic mice. Ann NY Acad Sci 692:149-160
199. Palmiter RD, Brinster RL, Hammer RE, Trumbauer ME, Rosenfeld MG, Bimberg NC, Evans RM 1982 Dramatic growth of mice that develop from eggs microinjected with metallothionein-growth hormone fusion genes. Nature 300:611-615
200. Palmiter RD, Norstedt RE, Gelinas RE, Hammer RE, Brinster RL 1983 Metallothionein-human GH fusion genes stimulate growth of mice. Science 222:809-814
201. Mathews LS, Hammer RE, Brinster RL, Palmiter RD 1988 Expression of insulin-like growth factor I in transgenic mice with elevated levels of growth hormone is correlated with growth. Endocrinology 123:433-437
202. Mathews LS, Hammer RE, Behringer RR, D’Ercole AJ, Bell GI, Brinster RL, Palmiter RD 1988 Growth enhancement of transgenic mice expressing human insulin-like growth factor-I. Endocrinology 123:2827-2833
203. Behringer RR, Mathews LS, Palmiter RD, Brinster RL 1988 Dwarf mice produced by genetic ablation of growth hormone-expressing cells. Genes Dev 2:453-461
204. Liu J-P, Baker J, Perkins AS, Robertson EJ, Efstratiadis A 1993 Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igflr). Cell 75:73-82
205. Baker J, Liu J-P, Robertson EJ, Efstratiadis A 1993 Role of insulinlike growth factors in embryonic and postnatal growth. Cell 75: 73-82
206. Rappolee DA, Sturm KS, Behrendtsen O, Schultz GA, Pedersen RA, Werb Z 1992 Insulin-like growth factor II acts through an endogenous growth pathway regulated by imprinting in early mouse embryos. Genes Dev 6:939-952
207. Telford NA, Hogan A, Franz CR, Schultz GA 1990 Expression of genes for insulin and insulin-like growth factors and receptors in early postimplantation mouse embryos and embryonal carcinoma cells. Mol Reprod Dev 27:81-92
208. Powell-Braxton L, Hollingshead P, Warburton C, Dowd M, Pitts-Meek S, Dalton D, Gillett N, Stewart TA 1993 IGF-I is required for normal embryonic development in mice. Genes Dev 7:2609-2617
209. Guler HP, Zapf J, Froesch ER 1987 Short-term metabolic effects of recombinant human insulin-like growth factor-I in healthy adults. N Engl J Med 317:137-140
210. Boulware SD, Tamborlane WV, Matthews LS, Sherwin RS 1992 Diverse effects of insulin-like growth factor I on glucose, lipid, and amino acid metabolism. Am J Physiol 262:E130-E133
211. Turkalj I, Keller U, Ninnis R, Vosmeer S, Stauffacher W 1992 Effect of increasing doses of recombinant human insulin-like growth factor-I on glucose, lipid, and leucine metabolism in man. J Clin Endocrinol Metab 75:1186-1191
212. Mauras N, Horber FF, Haymond MW 1992 Low dose recombinant human insulin-like growth factor-I fails to affect protein anabolism but inhibits islet cell secretion in humans. J Clin Endocrinol Metab 75:1192-1197
213. Zenobi PD, Graf S, Ursprung H, Froesch ER 1992 Effects of insulin-like growth factor-I on glucose tolerance, insulin levels, and insulin secretion. J Clin Invest 89:1908-1913
214. Kerr D, Tamborlane WV, Rife F, Sherwin RS 1993 Effect of insulin-like growth factor-1 on the responses to and recognition of hypoglycemia in humans. A comparison with insulin. J Clin Invest 91:141-147
215. Clemmons DR, Smith-Banks A, Underwood LE 1992 Reversal of diet-induced catabolism by infusion of recombinant insulin-like growth factor-I (IGF-I) in humans. J Clin Endocrinol Metab 75: 234-238
216. Kupfer SR, Underwood LE, Baxter RC, Clemmons DR 1993 Enhancement of the anabolic effects of growth hormone and insulinlike growth factor I by use of both agents simultaneously. J Clin Invest 91:391-396
217. Young SC, Underwood LE, Celniker A, Clemmons DR 1992 Effects of recombinant insulin-like growth factor-I (IGF-I) and growth hormone on serum IGF-binding proteins in calorically restricted adults. J Clin Endocrinol Metab 75:603-608
218. Miell JP, Taylor AM, Jones J, Buchanan CR, Rennie J, Sherwood R, Leicester R, Ross RJ 1992 Administration of human recombinant insulin-like growth factor-I to patients following major gastrointestinal surgery. Clin Endocrinol (Oxf) 37:542-551
219. Guler HP, Schmid C, Zapf J, Froesch ER 1989 Effects of recombinant insulin-like growth factor-I on insulin secretion and renal function in normal human subjects. Proc Natl Acad Sci USA 86: 2868-2872
220. Hirschberg R, Brunori G, Kopple JD, Guler HP 1993 Effects of insulin-like growth factor I on renal function in normal men. Kidney Int 43:387-397
221. Schoenle EJ, Zenobi PD, Torresani T, Werder EA, Zachmann M, Froesch ER 1991 Recombinant human insulin-like growth factor I (rhIGF I) reduces hyperglycaemia in patients with extreme insulin resistance. Diabetologia 34:675-679
222. Quin JD, Fisher BM, Paterson KR, Inoue A, Beastall GH, Mac-Cuish AC 1990 Acute response to recombinant insulin-like growth factor I in a patient with Mendenhall’s syndrome. N Engl J Med 323:1425-1426
223. Kuzuya H, Matsuura N, Sakamoto M, Makino H, Sakamoto Y, Kadowaki T, Suzuki Y, Kobayashi M, Akazawa Y, Nomura M, Yoshimasa Y, Kasuga M, Goji K, Nagataki S, Oyasu H, Imura H 1993 Trial of insulin-like growth factor I therapy for patients with extreme insulin resistance syndromes. Diabetes 42:696-705
224. Usala AL, Madigan T, Burguera B, Sinha MK, Caro JF, Cunningham P, Powell JG, Butler PC 1992 Brief report: treatment of insulin-resistant diabetic ketoacidosis with insulin-like growth factor I in an adolescent with insulin-dependent diabetes. N Engl J Med 327: 853-857
225. Zenobi PD, Jaeggi-Groisman SE, Riesen WF, Roder ME, Froesch ER 1992 Insulin-like growth factor-I improves glucose and lipid ’ metabolism in type 2 diabetes mellitus. J Clin Invest 90:2234-2241
226. DeFronzo RA, Soman V, Sherwin RS, Hendler R, Felig P 1978 Insulin binding to monocytes and insulin action in human obesity, starvation, and refeeding. J Clin Invest 62:204-213
227. Rossetti L, Smith D, Shulman GI, Papachristou D, DeFronzo RA 1987 Correction of hyperglycemia with phlorizin normalizes tissue sensitivity to insulin in diabetic rats. J Clin Invest 79:1510-1515
228. Walker JL, Ginalska Malinowska M, Romer TE, Pucilowska JB, Underwood LE 1991 Effects of the infusion of insulin-like growth factor I in a child with growth hormone insensitivity syndrome (Laron dwarfism). N Engl J Med 324:1483-1488
229. Walker JL, Van Wyk JJ, Underwood LE 1992 Stimulation of statural growth by recombinant insulin-like growth factor I in a child with growth hormone insensitivity syndrome (Laron type). J Pediatr 121:641-646
230. Laron Z, Klinger B, Erster B, Anin S 1988 Effect of acute administration of insulin-like growth factor I in patients with Laron-type dwarfism. Lancet 2:1170-1172
231. Wood WI, Cachianes G, Henzel WJ, Winslow GA, Spencer SA, Hellmiss R, Martin JL, Baxter RC 1988 Cloning and expression of the GH dependent insulin like growth factor binding protein. Mol Endocrinol 2:1176-1185
232. Leong SR, Baxter RC, Camerato T, Dai J, Wood WI 1992 Structure and functional expression of acid labile subunit of the insulin-like growth factor binding protein complex. Mol Endocrinol 6:870-876
233. Baxter RC, Martin JL 1989 Structure of the Mr 140, 000 growth hormone-dependent insulin-like growth factor binding protein complex: determination by reconstitution and affinity labeling. Proc Natl Acad Sci USA 86:6898-6902
234. Guler H-P, Zapf J, Schmid C, Froesch ER 1989 Insulin-like growth factors I and II in healthy man. Estimations of half-lives and production rates. Acta Endocrinol (Copenh) 121:753-758
235. Hodgkinson SC, Davis SR, Moore LG, Henderson HV, Gluck-man PD 1989 Metabolic clearance of insulin-like growth factor-II in sheep. J Endocrinol 123:461-468
236. Bayne ML, Applebaum J, Chicchi GG, Hayes NS, Green BG, Cascieri MA 1988 Structural analogues of human insulin-like growth factor-I with reduced affinity for serum binding protein and the type II insulin-like growth factor receptor. J Biol Chem 263: 6233-6239
237. Cascieri MA, Chicchi GC, Applebaum J, Hayes NS, Green BG, Bayne ML 1988 Mutants of human insulin like growth factor I with reduced affinity for the type I insulin like growth factor receptor. Biochemistry 27:3229-3233
238. Zapf J, Hauri C, Waldvogel M, Futo E, Hasler K, Binz K, Guler HP, Schmid C, Froesch ER 1989 Recombinant human insulin-like growth factor I induces its own specific carrier protein in hypoph-ysectomized and diabetic rats. Proc Natl Acad Sci USA 86:3813-3817
239. Davenport ML, Clemmons DR, Miles MW, Camacho-Hubner C, D’Ercole AJ, Underwood LE 1990 Regulation of serum insulin-like growth factor I (IGF-I) and IGF binding proteins during rat pregnancy. Endocrinology 127:1278-1286
240. Hossenlopp P, Segovia B, Lassare C, Roghani M, Bredon M, Binoux M 1990 Evidence of enzymatic degradation of insulin-like growth factor binding protein in 150 k complex during pregnancy. J Clin Endocrinol Metab 71:797-805
241. Giudice LC, Farrell EM, Pham H, Lamson G, Rosenfeld RG 1990 Insulin-like growth factor binding proteins in maternal serum throughout gestation and in the puerperium: effects of a pregnancy-associated serum protease activity. J Clin Endocrinol Metab 71:806-816
242. Cohen P, Peehl DM, Staney TA, Wilson KF, Clemmons DR, Rosenfeld RE 1993 Elevated levels of insulin like growth factor binding protein-2 in prostate cancer patients. J Clin Endocrinol Metab 76:1031-1035
243. Davenport ML, Isley WL, Pucilowska JB, Pemberton LB, Lyman B, Underwood LE, Clemmons DR 1992 Insulin-like growth factor-binding protein-3 proteolysis is induced after elective surgery. J Clin Endocrinol Metab 75:590-595
244. Binoux M, Roghani M, Hossenlopp P, Hardouin S, Gourmelen M 1991 Molecular forms of human IGF binding proteins: physiological implications. Acta Endocrinol (Copenh) 124 (Suppl 2):41-47
245. Martin JL, Baxter RC 1992 Insulin-like growth factor binding protein-3: biochemistry and physiology. Growth Regul 2:88-99
246. Baxter RC 1990 Glycosaminoglycans inhibit formation of the 140 kDa insulin-like growth factor-binding protein complex. Biochem J 271:773-777
247. Young SC, Miles MV, Clemmons DR 1992 Determination of the pharmacokinetic profiles of insulin-like growth factor binding pro-teins-1 and-2 in rats. Endocrinology 131:1867-1873
248. Bar RS, Boes M, Clemmons DR, Busby WH, Sandra A, Dake BL, Booth BA 1990 Insulin differentially alters transcapillary movement of intravascular IGFBP-1, IGFBP-2 and endothelial cell IGF binding proteins in rat heart. Endocrinology 127:497-499
249. McCusker RH, Campion DR, Clemmons DR 1988 The ontogeny and regulation of a 31, 000 Mr insulin-like growth factor /somatomedin (IGF) binding protein in fetal porcine plasma and sera. Endocrinology 122:2071-2079
250. McCusker RH, Cohick WS, Busby WH, Clemmons DR 1991 Evaluation of the developmental and nutritional changes in porcine insulin-like growth factor binding protein-1 and 2 serum level by immunoassay. Endocrinology 129:2631-2638
251. Pucilowska JB, Davenport ML, Kabir I, Clemmons DR, Thissen JP, Butler T, Underwood LE 1993 The effect of dietary protein supplementation on insulin like growth factors (IGF’s) and IGF binding proteins in children with shigellosis. J Clin Endocrinol Metab 77:1516-1521
252. Fowlkes J, Freemark M 1992 Evidence for a novel insulin-like growth factor (IGF)-dependent protease regulating IGF-binding protein-4 in dermal fibroblasts. Endocrinology 131:2071-2076
253. Conover CA, Kiefer MC, Zapf J 1993 Posttranslational regulation of insulin-like growth factor binding protein-4 in normal and transformed human fibroblasts. Insulin-like growth factor dependence and biological studies. J Clin Invest 91:1129-1137
254. Lewitt MS, Denyer GS, Cooney GJ, Baxter RC 1991 Insulin-like growth factor binding protein-1 modulates blood glucose levels. Endocrinology 129:2254-2256
255. Hardouin S, Gourmelen M, Noguiez P, Seurin D, Roghani M, Bouc YL, Povoa G, Merimee TJ, Hossenlopp P, Binoux M 1989 Molecular forms of serum insulin-like growth factor (IGF)-binding proteins in man: relationship with growth hormone and IGFs and physiological significance. J Clin Endocrinol Metab 69:1291-1301
256. Zapf J, Schmid C, Guler HP, Waldvogel M, Hauri C, Futo E, Hossenlopp P, Binoux M, Froesch ER 1990 Regulation of binding proteins for insulin-like growth factors in humans: increased expression of IGF binding proteins during treatment of healthy adults and in patients with extrapancreatic tumor. J Clin Invest 86:952-961
257. Lewitt MS, Saunders H, Baxter RC 1993 Bioavailability of insulin like growth factors (IGF’s) in rats determined by molecular distribution of human IGF binding protein-3. Endocrinology 133:1797-1802
258. Zapf J, Waldvogel M, Froesch ER 1975 Binding of nonsuppressible insulin-like activity to human serum: evidence for a carrier protein. Arch Biochem Biophys 168:638-645
259. Hintz RL, Liu F 1977 Demonstration of specific plasma protein binding sites for somatomedin. J Clin Endocrinol Metab 45:988-995
260. Zapf J, Schoenle E, J agars G, Sand I, Grunwald J, Froesch ER 1979 Inhibition of the action of nonsuppressible insulin-like activity on isolated fat cells by binding to its carrier protein. J Clin Invest 63:1077-1084
261. Elgin RG, Busby WH, Clemmons DR 1987 An insulin-like growth factor binding protein enhances the biologic response to IGF-I. Proc Natl Acad Sci USA 84:3254-3258
262. Blum WF, Jenne EW, Reppin F, Kietzmann K, Ranke MB, Bierich JR 1989 Insulin-like growth factor I (IGF-I) binding protein complex is a better mitogen than free IGF-I. Endocrinology 125:766-772
263. Bar RS, Booth BA, Bowes M, Drake BL 1989 Insulin-like growth factor binding proteins from cultured endothelial cells: purification, characterization, and intrinsic biologic activities. Endocrinology 125:1910-1920
264. Jones JI, D’Ercole AJ, Camacho-Hubner C, Clemmons DR 1991 Phosphorylation of insulin-like growth factor binding protein in cell culture and in vivo: effects on affinity for IGF-I. Proc Natl Acad Sci USA 88:7481-7485
265. Mukku VR, Chu HR, Phosphorylation of insulin-like growth factor binding proteins by mammalian cells. Program of the the 72nd Annual Meeting of The Endocrine Society, Atlanta GA, 1990 (Abstract 190)
266. Jones JI, Gockerman A, Clemmons DR, Insulin-like growth factor binding protein-5 (IGFBP-5) binds to extracellular matrix and is phosphorylated. Program of the 74th Annual Meeting of The Endocrine Society, San Antonio TX, 1992 (Abstract 1284)
267. Rechler MM, Nissley SP 1990 Insulin like growth factors. In: Spom MB, Robert AB (eds) Peptide Growth Factors and Their Receptors. Springer Verlag, Berlin, pp 263-367
268. Ritvos O, Ranta T, Jalkanen J, Suikkari AM, Voutilainen R, Bohn H, Rutanen EM 1988 Insulin-like growth factor (IGF) binding protein from human decidua inhibits the binding and biological action of IGF-I in cultured choriocarcinoma cells. Endocrinology 122:2150-2157
269. Busby WH, Klapper DG, Clemmons DR 1988 Purification of a 31000 dalton insulin like growth factor binding protein from human amniotic fluid. J Biol Chem 263:14203-14210
270. Frauman AG, Tsuzaki S, Moses AC 1989 The binding characteristics and biological effects in FRTL5 cells of placental protein-12, and insulin-like growth factor-binding protein purified from human amniotic fluid. Endocrinology 124:2289-2296
271. Burch WW, Correa J, Shaveley JE, Powell DR 1990 The 25 k Dalton insulin-like growth factor (IGF) binding protein inhibits both basal and IGF mediated growth in chick embryonic pelvic cartilage in vitro. J Clin Endocrinol Metab 70:173-180
272. Liu L, Brinkman A, Blat C, Harel L 1991 IGFBP-1, an insulin like growth factor binding protein is a cell inhibitor. Biochem Biophys Res Commun 174:673-679
273. Campbell PG, Novack JF 1991 Insulin like growth factor binding protein inhibits IGF action in human osteosarcoma cells. J Cell Physiol 149:293-300
274. Okajima T, Iwashita M, Takeda Y, Sakamoto S, Tanabe T, Yasuda T, Rosenfeld RG 1993 Inhibitory effects of insulin-like growth factor (IGF)-binding proteins-1 and-3 on IGF-activated glucose consumption in mouse BALB/c 3T3 fibroblasts. J Endocrinol 136: 457-470
275. Rutanen E-M, Pekonen F, Makinen T 1988 Soluble 34K binding protein inhibits the binding of insulin-like growth factor I to its own cell receptors in human secretory phase endometrium: evidence for autocrine/paracrine regulation of growth factor action. J Clin Endocrinol Metab 66:173-180
276. Miell JP, Taylor AM, Jones J, Holly JMP, Gaillard RC, Pralong FF, Ross RJM, Blum WF 1993 The effects of dexamethasone treatment on immunoreactive and bioactive insulin like growth factors (IGF’s) and IGF binding proteins in normal volunteers. J Endocrinol 136:525-533
277. Angervo M, Koistinen R, Suikkari AM, Seppala M 1991 Insulin like growth factor binding protein-1 inhibits DNA amplification induced by insulin-like growth factor I in human granulosa-luteal cells. Hum Reprod 6:770-773
278. Clemmons DR, Gardner LI 1990 A plasma factor is required for IGFBP-1 to potentiate DNA synthesis. J Cell Physiol 145:129-135
279. Camacho-Hubner C, McCusker RH, Clemmons DR 1991 Secretion and biological actions of insulin-like growth factor binding proteins in two human tumor-derived cell lines in vitro. J Cell Physiol 148:281-289
280. Clemmons DR, Cascieri MA, Camacho-Hubner C, McCusker RH, Bayne ML 1990 Discrete alterations of the IGF-I molecule that alter its affinity for IGF binding proteins result in changes in bioactivity. J Biol Chem 265:12210-12216
281. Koistinen R, Itkinen P, Selenius P, Seppala M 1990 Insulin like growth factor binding protein-1 inhibits binding of IGF-I on fetal skin fibroblasts but stimulates their DNA synthesis. Biochem Biophys Res Commun 173:408-415
282. Kratz G, Lake M, Ljungstrom K, Forsberg G, Haegerstrand A, Gidlund M 1992 Effect of recombinant IGF binding protein-1 on primary cultures of human keratinocytes and fibroblasts: selective enhancement of IGF-1 but not IGF-2-induced cell proliferation. Exp Cell Res 202:381-385
283. Busby WH, Hossenlopp P, Binoux M, Clemmons DR 1989 Purified preparations of the amniotic fluid IGF binding protein contain multimeric forms that are biologically active. Endocrinology 125:773-777
284. Clemmons DR 1989 The role of insulin like growth factor binding proteins in controlling the expression of IGF actions. In: LeRoith D, Raizada MK (eds) Molecular and Cellular Biology of Insulin-like Growth Factors and Their Receptors. Plenum, New York, pp 381-394
285. Hynes RO 1992 Integrins: versatility, modulation, and signaling in cell adhesion. Cell 69:11-25
286. Brewer MT, Stetler GL, Squires CH, Thompson RC, Busby WH, Clemmons DR 1988 Cloning, characterization and expression of a human insulin-like growth factor binding protein. Biochem Biophys Res Commun 152:1289-1297
287. Jones JI, Gockerman A, Busby WH, Wright G, Clemmons DR 1993 Insulin-like growth factor binding protein 1 stimulates cell migration and binds to the a5β1 integrin by means of its Arg-Gly-Asp sequence. Proc Natl Acad Sci USA 90:10553-10557
288. Delhanty PJD, Han V, An RGD to RGE mutation in the putative membrane binding domain of IGFBP-2 inhibits its potentiation of IGF-II induced thymidine uptake by SCP cells. Program of the 75th Annual Meeting of The Endocrine Society, Las Vegas NV, 1993 (Abstract 22:56)
289. Frost RA, Tseng L 1991 Insulin-like growth factor binding protein-1 is phosphorylated by cultured human endometrial stromal cells and multiple protein kinases in vitro. J Biol Chem 266:18082-18088
290. Koistinen R, Angervo M, Leinonen P, Hakala T, Seppala M 1993 Phosphorylation of insulin-like growth factor binding protein-1 in human amniotic fluid and decidua from early to late pregnancy. Clin Chim Acta 215:189-199
291. Jyung RW, Mustoe TA, Busby WH, Clemmons DR 1994 Increased wound breaking strength induced by insulin-like growth factor-1 in combination with IGF binding protein-1. Surgery 115:233-239
292. Jones JI, Busby WH, Wright G, Smith CE, Kimack NM, Clemmons DR 1993 Identification of the sites of phosphorylation in insulin-like growth factor binding protein-1: regulation of its affinity by phosphorylation of serine 101. J Biol Chem 268:1125-1131
293. Pearson RB, Kemp BE 1991 Protein kinase phosphorylation site sequences and consensus specificity motifs: tabulations. Methods Enzymol 200:62-81
294. Knauer DJ, Smith GL 1980 Inhibition of biologic activity of multiplication stimulating activity by binding to its carrier protein. Proc Natl Acad Sci USA 77:7252-7254
295. Reeve JG, Schwander J, Bleehen NM 1993IGFBP-2: an important regulator of insulin like growth factor action in human lung tumors. Growth Regul 3:82-84
296. Ross M, Francis GL, Szabo L, Wallace JC, Ballard FJ 1989 Insulinlike growth factor (IGF)-binding proteins inhibit the biological activities of IGF-I and IGF-2 but not des-(l-3)-IGF-I. Biochem J 258:267-272
297. Feyen JH, Evans DB, Binkert C, Heinrich GF, Geisse S, Koeher HP 1991 Recombinant human CYS 281 insulin like growth factor binding protein-2 inhibits both basal and insulin like growth factor I stimulated proliferation and collagen synthesis in fetal rat cal-varia. J Biol Chem 266:19469-19474
298. Schwander J, Mary J-L, Landwehr J, Boni M, Margot J, Binkert C 1989 The regulation of the mRNA of an insulin-like growth factor binding protein (IBP-2) in the rat. In: Drop SLS, Hintz RL (eds) Insulin-like Growth Factor Binding Proteins. Excerpta Medica International Congress Series 881. Elsevier Science Publishers BV, Amsterdam, pp 125-131
299. Bourner MJ, Busby WH, Seigel NR, Krivi GG, McCusker RH, Clemmons DR 1992 Cloning and sequence determination of bovine insulin-like growth factor binding protein-2 (IGFBP-2): comparison of its structural and functional properties with IGFBP-1. J Cell Biochem 48:215-226
300. DeMellow JSM, Baxter RC 1988 Growth hormone dependent insulin-like growth factor binding protein both inhibits and potentiates IGF-I stimulated DNA synthesis in skin fibroblasts. Biochem Biophys Res Commun 156:199-204
301. Blat C, Delbe J, Villaudy J, Chatelain PG, Golde A, Harel L 1989 Inhibitory diffusible factor 45 bifunctional activity as a cell growth inhibitor and as an insulin-like growth factor I-binding protein. J Biol Chem 264:12449-12454
302. Clemmons DR, Elgin RG, Han VKM, Casella SJ, D’Ercole AJ, Van Wyk JJ 1986 Cultured fibroblast monolayers secrete a protein that alters the cellular binding of somatomedin-C/insulin-like growth factor I. J Clin Invest 77:1548-1556
303. Clemmons DR, Han VKM, Elgin RG, D’Ercole AJ 1987 Alterations in the synthesis of a fibroblast surface associated 35 K protein modulates the binding of somatomedin-C/insulin-like growth factor I. Mol Endocrinol 1:339-347
304. McCusker RH, Camacho-Hubner C, Bayne ML, Cascieri MA, Clemmons DR 1990 Insulin-like growth factor (IGF) binding to human fibroblast and glioblastoma cells: the modulating effect of cell released IGF binding proteins (IGFBPs). J Cell Physiol 144: 244-253
305. McCusker RH, Busby WH, Dehoff MH, Camacho-Hubner C, Clemmons DR 1991 Insulin-like growth factor (IGF) binding to cell monolayers is directly modulated by the addition of IGF binding proteins. Endocrinology 129:939-949
306. Bicsak TA, Shimonaka M, Malkowski M, Ling N1990 Insulin-like growth factor-binding protein (IGF-BP) inhibition of granulosa cell function: effect of cyclic adenosine 3’, 5’-monophosphate, deoxyribonucleic acid synthesis, and comparison with the effect of an IGF-I antibody. Endocrinology 126:2184-2189
307. Schmid C, Rutishauser J, Schlapfer I, Froesch ER, Zapf J 1991 Intact but not truncated insulin-like growth factor binding protein-3 (IGFBP-3) blocks IGF-I-induced stimulation of osteoblasts: control of IGF signalling to bone cells by IGFBP-3-specific proteolysis? Biochem Biophys Res Commun 179:579-585
308. Andress DL, Bimbaum RS 1992 Human osteoblast-derived insulin-like growth factor (IGF) binding protein-5 stimulates osteoblast mitogenesis and potentiates IGF action. J Biol Chem 267:22467-22472
309. Walton PE, Gopinath R, Etherton TD 1989 Porcine insulin-like growth factor (IGF) binding protein blocks IGF-I action on porcine adipose tissue. Proc Soc Exp Biol Med 190:315-319
310. Cohen P, Lamson G, Okajima T, Rosenfeld RG 1993 Transfection of the human IGFBP-3 gene into Balb/c fibroblasts: a model for the cellular functions of IGFBPs. Growth Regul 3:23-26
311. Ricciarelli E, Hernandez ER, Tedeschi C, Botero LF, Kokia E, Rohan RM, Rosenfeld RG, Albiston AL, Herington AC, Adashi EY 1992 Rat ovarian insulin-like growth factor binding protein-3: a growth hormone-dependent theca-interstitial cell-derived antigonadotropin. Endocrinology 130:3092-3094
312. Villaudy J, Delbe J, Blat C, Desaulty G, Golde A, Harel L 1991 An IGF binding protein is an inhibitor of IGF stimulation. J Cell Physiol 149:492-496
313. Imbenotte J, Liu L, Desauty G, Harel L 1992 Stimulation by TGF beta of chick embryo fibroblasts-inhibition by an IGFBP-3. Exp Cell Res 199:229-233
314. Liu L, Delbe J, Blat C, Zapf J, Harel L 1992 Insulin-like growth factor binding protein (IGFBP-3), an inhibitor of serum growth factors other than IGF-I and-II. J Cell Physiol 153:15-21
315. Oh Y, Muller HL, Lamson G, Rosenfeld RG 1993 Insulin-like growth factor (IGF)-independent action of IGF-binding protein-3 in Hs578T human breast cancer cells. J Biol Chem 268:14964-14971
316. Oh Y, Muller HL, Pham H, Rosenfeld RG 1993 Demonstration of receptors for insulin-like growth factor binding protein-3 on Hs578T human breast cancer cells. J Biol Chem 268:26045-26048
317. Cornell HJ, Embery G, Herington AC 1986 Association of insulin like growth factors with metabolically inactive and active carrier bound complexes in sera. J Endocrinol 241:744-749
318. Conover CA, Ronk M, Lombana F, Powell DR 1990 Structural and biological characterization of bovine insulin like growth factor binding protein-3. Endocrinology 127:2795-2803
319. Ernst M, Rodan GA 1990 Increased activity of insulin-like growth factor (IGF) in osteoblastic cells in the presence of growth hormone (GH): positive correlation with the presence of the GH-induced IGF-binding protein BP-3. Endocrinology 127:807-814
320. Conover CA 1991 Glycosylation of insulin like growth factor binding protein-3 (IGFBP-3) is not required for potentiation of IGF-I action: evidence for processing of cell bound IGFBP-3. Endocrinology 129:3259-3268
321. Conover CA, Powell DR 1991 Insulin-like growth factor (IGF) binding protein-3 blocks IGF-I-induced receptor down-regulation and cell densitization in cultured bovine fibroblasts. Endocrinology 129:710-716
322. Conover CA 1991 A unique receptor independent mechanism by which insulin like growth factor I regulates the availability of insulin like growth factor binding protein in normal and transformed fibroblasts. J Clin Invest 88:1354-1361
323. Sommer A, Maack CA, Spratt SK, Mascarenhas D, Tressel TJ, Rhodes ET, Lee R, Roumas M, Tatsuno GP, Flynn JA, Gerber N, Taylor J, Cudny H, Nanney L, Hunt TK, Spencer EM 1991 Molecular genetics and actions of recombinant insulin like growth factor binding protein-3. In: Spencer EM (eds) Modern Concepts of Insulin-like Growth Factors. Elsevier, New York, pp 715-728
324. Hamon GA, Hunt TK, Spencer EM 1993 In vivo effects of systemic insulin-like growth factor-I alone and complexed with insulin-like growth factor binding protein-3 on corticosteroid suppressed wounds. Growth Regul 3:53-56
325. Clark RG, Mortensen D, Reifsynder D, Mohler M, Etcheverry T, Mukku V 1993 Recombinant human insulin-like growth factor binding protein-3 (rhIGFBP-3): effects on the glycemic and growth promoting activities of rhIGF-1 in the rat. Growth Regul 3:50-52
326. Stewart CH, Bates DC, Calder TA, Woodall S, Pell JM 1993 Potentiation of insulin like growth factor (IGF-I) activity by an antibody: supportive evidence for enhancement of IGF-I bioavailability in vivo by IGF binding proteins. Endocrinology 133:1462-1465
327. Mohan S, Bautista CM, Wergedal J, Baylink DJ 1989 Isolation of an inhibitory insulin-like growth factor (IGF) binding protein from bone cell-conditioned medium: a potential local regulator of IGF action. Proc Natl Acad Sci USA 86:8338-8342
328. Ui M, Shimonaka M, Shimasaki S, Ling N 1989 An insulin-like growth factor-binding protein in ovarian follicular fluid blocks follicle-stimulating hormone-stimulated steroid production by ovarian granulosa cells. Endocrinology 125:912-916
329. Culouscou JM, Shoyab M 1991 Purification of a colon cancer cell growth inhibitor and its identification as insulin-like growth factor binding protein-4. Cancer Res 51:2813-2819
330. LaTour D, Mohan S, Linkhart TA, Baylink DJ, Strong DD 1990 Inhibitory insulin-like growth factor-binding protein: cloning, complete sequence, and physiological regulation. Mol Endocrinol 4:1806-1814
331. Perkel VS, Mohan S, Baylink DJ, Linkhart TA 1990 An inhibitory insulin like growth factor binding protein (In-IGFBP) from human prostatic cell conditioned medium reveals N-terminal sequence identity with bone derived IN-IGFBP. J Clin Endocrinol Metab 71:533-535
332. Cheung PT, Smith EP, Shimasaki S, Ling N, Chemausek S 1991 Characterization of insulin-like growth factor binding protein (IGFBP-4) produced by B104 rat neuronal cell line: chemical and biologic properties and differential synthesis by sublines. Endocrinology 129:1006-1015
333. Kiefer MC, Schmid C, Waldvogel M, Schlapfer I, Futo E, Masiarz FR, Green K, Barr PJ, Zapf J 1992 Characterization of recombinant human insulin-like growth factor binding proteins 4, 5, and 6 produced in yeast. J Biol Chem 267:12692-12699
334. Lin T, Wang D, Nagpal ML, Shimasaki S, Ling N1993 Expression and regulation of insulin-like growth factor-binding protein-1,-2,-3, and-4 messenger ribonucleic acids in purified rat Leydig cells and their biological effects. Endocrinology 132:1898-1904
335. Cohick WS, Gockerman A, Clemmons DR 1993 Vascular smooth muscle cells synthesize two forms of insulin-like growth factor binding proteins which are regulated differently by the insulin-like growth factors. J Cell Physiol 157:52-60
336. Ling NC, Liu XJ, Malkowski M, Guo YL, Erickson GF, Shimasaki S 1993 Structural and functional studies of insulin-like growth factor binding proteins in the ovary. Growth Regul 3:70-74
337. Jones JI, Gockerman A, Busby WHJ, Camacho Hubner C, Clem mons DR 1993 Extracellular matrix contains insulin-like growth factor binding protein-5: potentiation of the effects of IGF-I. J Cell Biol 121:679-687
338. Bautista CM, Baylink DJ, Mohan S 1991 Isolation of a novel insulin-like growth factor (IGF) binding protein from human bone: a potential candidate for fixing IGF-II in human bone. Biochem Biophys Res Commun 176:756-763
339. Andress DL, Bimbaum RS 1991 A novel human insulin-like growth factor binding protein secreted by osteoblast cells. Biochem Biophys Res Commun 176:213-218
340. Andress DL, Loop SM, Zapf J, Keifer MC 1993 Carboxytruncated insulin like growth factor binding protein-5 stimulates mitogenesis in osteoblast cells. Biochem Biophys Res Commun 195:25-30
341. Conover CA, Kiefer MC 1993 Regulation and biological effect of endogenous insulin-like growth factor binding protein-5 in human osteoblastic cells. J Clin Endocrinol Metab 76:1153-1159
342. Rohan RM, Ricciarelli E, Kiefer MC, Resnick CE, Adashi EY 1993 Rat overian insulin like growth factor binding protein-6: a hormonally regulated theca-interstitial-selective species with limited antigonadotropic activity. Endocrinology 132:2507-2512
343. Cascieri MA, Hayes NS, Bayne ML 1989 Characterization of the increased biological potency in BALB/C 3T3 cells of two analogs of human insulin-like growth factor I which have reduced affinity for the 28 K cell-derived binding protein. J Cell Physiol 139:181-188
344. Read LC, Tomas FM, Howarth GS, Martin AA, Edson KJ, Gillespie CM, Owens PC, Ballard FJ 1992 Insulin-like growth factor-I and its N-terminal modified analogues induce marked gut growth in dexamethasone-treated rats. J Endocrinol 133:421-431
345. Tomas FM, Knowles SE, Owens PC, Read LC, Chandler CS, Gorzosky SE, Ballard FJ 1991 Effects of full-length and truncated insulin-like growth factor I on nitrogen balance and muscle protein metabolism in nitrogen restricted rats. J Endocrinol 128: 91-105